E. Terzoli
- Oncology top 1%
- Cancer Treatment and Pharmacology 46
- Colorectal Cancer Treatments and Studies 20
- HER2/EGFR in Cancer Research 13
- Neutropenia and Cancer Infections 12
- Pancreatic and Hepatic Oncology Research 10
- Cancer Research top 5%
- Breast Cancer Treatment Studies 28
- Hematology top 2%
-
- Lung Cancer Treatments and Mutations 9
-
- Estrogen and related hormone effects 9
- Co-authors
- Roberto StasiSergio AmadoriPatrizia BeccagliaCecilia NisticòEmilio BriaDiana GiannarelliPaolo CarliniMichèle Milella
- Cited by
- OncologyCancer ResearchHematology
- Journals
- Journal of Clinical Oncology (24 papers)Cancer (13 papers)European Journal of Cancer (8 papers)
- Partner nations
- ItalyUnited StatesMalaysia
In The Last Decade
E. Terzoli
97 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Oncology 1.9k
- Cancer Research 531
- Hematology 366
- Pulmonary and Respiratory Medicine 644
- Pediatrics, Perinatology and Child Health 330
Countries citing papers authored by E. Terzoli
This map shows the geographic impact of E. Terzoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Terzoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Terzoli more than expected).
Fields of papers citing papers by E. Terzoli
This network shows the impact of papers produced by E. Terzoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Terzoli. The network helps show where E. Terzoli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E. Terzoli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 47 | |
| 2 | 2007 | 12 | |
| 3 | 2007 | 87 | |
| 4 | 2006 | 15 | |
| 5 | 2006 | 26 | |
| 6 | 2006 | 6 | |
| 7 | 2005 | 71 | |
| 8 | 2005 | 9 | |
| 9 | 2005 | 21 | |
| 10 | 2005 | 16 | |
| 11 | 2005 | 26 | |
| 12 | 2003 | 16 | |
| 13 | 2000 | 30 | |
| 14 | 1999 | 28 | |
| 15 | 1999 | 14 | |
| 16 | 1999 | 16 | |
| 17 | 13-cis retinoic acid and interferon alfa-2a in the treatment of metastatic renal cell carcinoma. | 1998 | 6 |
| 18 | 1997 | 96 | |
| 19 | 1997 | 23 | |
| 20 | Combined therapy with bleomycin and some immunological implications. | 1976 | 1 |
About E. Terzoli
E. Terzoli is a scholar working on Oncology, Cancer Research, Hematology, Genetics and Pulmonary and Respiratory Medicine, having authored 102 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (46 papers), Breast Cancer Treatment Studies (28 papers), Colorectal Cancer Treatments and Studies (20 papers), HER2/EGFR in Cancer Research (13 papers), Neutropenia and Cancer Infections (12 papers), Pancreatic and Hepatic Oncology Research (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Estrogen and related hormone effects (9 papers). The work is most often cited by research in Oncology (1.9k citations), Cancer Research (531 citations), Hematology (366 citations), Pulmonary and Respiratory Medicine (644 citations) and Pediatrics, Perinatology and Child Health (330 citations). E. Terzoli has collaborated with scholars based in Italy, United States and Malaysia. Frequent co-authors include Roberto Stasi, Sergio Amadori, Patrizia Beccaglia, Cecilia Nisticò, Emilio Bria, Diana Giannarelli, Paolo Carlini, Michèle Milella, Francesco Cognetti and Federica Cuppone. Their work appears in journals such as Journal of Clinical Oncology, Cancer, European Journal of Cancer, Annals of Oncology and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.